Medicine and Dentistry
Pancreas Transplantation
100%
Diabetes Mellitus
56%
Diabetes
54%
Kidney Pancreas Transplantation
44%
Insulin Dependent Diabetes Mellitus
42%
Transplantation
42%
Kidney Graft
30%
Kidney Transplantation
24%
Immunosuppressive Treatment
22%
Graft Survival
22%
Complications of Diabetes Mellitus
18%
High Density Lipoprotein Cholesterol
16%
Cardiovascular Disease
14%
Triacylglycerol
14%
Kidney Function
12%
Hyperinsulinemia
12%
Patient with Type 1 Diabetes
10%
Intima-Media Thickness
10%
Creatinine
10%
Hyperglycemia
10%
Vascular Disease
10%
Chronic Kidney Disease
9%
Body Mass Index
9%
Heel
9%
Dual-Energy X-Ray Absorptiometry
9%
Anosmia
9%
Odor
9%
Primary Amenorrhea
9%
Lipoatrophic Diabetes Mellitus
9%
Liver Transplantation
9%
Arginine
9%
Salt Intake
9%
Acanthosis Nigricans
9%
Impaired Glucose Tolerance
9%
Hepatitis C
9%
Abdominal Fat
9%
Vitamin D
9%
Graft Failure
9%
Prolactin
9%
Mitogenesis
9%
Bacterial Toxin
9%
Cyclic GMP
9%
Reproductive Hormone
9%
Hypogonadism
9%
Thyrotropin Secreting Adenoma
9%
Multiple Endocrine Neoplasia Type I
9%
Vasoactive Intestinal Polypeptide
9%
Prevalence
9%
Glycated Hemoglobin
8%
Quality of Life
8%
Keyphrases
Pancreas Transplantation
45%
Type 1 Diabetes Mellitus (T1DM)
25%
Kidney Transplant
18%
Pancreas Transplant
14%
Type I Diabetes
13%
Carotid Intima-media Thickness (cIMT)
10%
Non-diabetic
10%
Transplantation Indications
9%
ADP-ribosylation
9%
Adrenocortical
9%
Adrenal Disease
9%
Vascular Disease
9%
Adipsic Hypernatremia
9%
Kallmann Syndrome
9%
Anosmia
9%
Outcome Prediction
9%
Insulin Independence
9%
Sense of Smell
9%
Primary Amenorrhea
9%
OLTx
9%
Sexual Development
9%
Pulsation Characteristics
9%
Lipoatrophic Diabetes
9%
Cyclosporine
9%
Pregnant Mare
9%
International Consensus Meeting
9%
Acanthosis Nigricans
9%
Severe Insulin Resistance
9%
Native American children
9%
Resistance Screening
9%
Native American Youth
9%
Simultaneous Pancreas-kidney Transplantation
9%
Recipient Evaluation
9%
Post-transplant Diabetes
9%
Dual Energy
9%
Lactogen
9%
Bacterial Toxins
9%
Anti-insulin Antibody
9%
Reproductive Hormones
9%
Somatostatinoma
9%
Insulin Pump
9%
Continuous Glucose Monitor
9%
Subcutaneous Insulin
9%
Reproductive Abnormalities
9%
Prospective Screening
9%
Thyrotropin-secreting pituitary Adenoma
9%
Metformin Therapy
9%
Hepatitis C Prevalence
9%
New-onset Diabetes
9%
Simultaneous Pancreas-kidney
9%